comparemela.com

Latest Breaking News On - Clinical work up - Page 1 : comparemela.com

The CELESTIAL Study: Cabozantinib Monotherapy in Advanced HCC Treatment

Dr R. Katie Kelley explains the design and results of the phase 3 CELESTIAL study investigating single-agent cabozantinib for the treatment of advanced hepatocellular carcinoma.

R katie kelleyCabozantinib monotherapyHepatocellular carcinomaRecent updatesEvolving treatment paradigmsRecent data updates hepatocellular carcinomaHcc treatmentsHepatocellular carcinoma treatmentsEarly stage hepatocellular carcinomaHcc risk factorsPatients with hccHcc prognosisHepatocellular carcinoma prognosisHepatocellular carcinoma diagnosisClinical work upMolecular testing hcc

Safety and Efficacy Data From the Retrospective Analysis of the CELESTIAL Study in Advanced HCC

R. Katie Kelley, MD, comments on the safety and efficacy data from the retrospective analysis of the CELESTIAL study in advanced hepatocellular carcinoma.

R katie kelleyHepatocellular carcinomaRecent updatesEvolving treatment paradigmsEfficacy data fromRetrospective analysisKatie kelleyRecent data updates hepatocellular carcinomaHcc treatmentsHepatocellular carcinoma treatmentsEarly stage hepatocellular carcinomaHcc risk factorsPatients with hccHcc prognosisHepatocellular carcinoma prognosisHepatocellular carcinoma diagnosis

Optimal Sequencing in Patients With Advanced HCC

Key opinion leaders discuss the sequencing of systemic therapy options for patients with advanced HCC.

Hepatocellular carcinomaRecent updatesEvolving treatment paradigmsPatients with advancedRecent data updates hepatocellular carcinomaHcc treatmentsHepatocellular carcinoma treatmentsEarly stage hepatocellular carcinomaHcc risk factorsPatients with hccHcc prognosisHepatocellular carcinoma prognosisHepatocellular carcinoma diagnosisClinical work upMolecular testing hccHcc diagnosis challenges

The Role of Adjuvant Therapy in Patients With Early-Stage HCC

Experts review data from IMbrave050 on the potential role of atezolizumab plus bevacizumab in the adjuvant setting for HCC.

Hepatocellular carcinomaRecent updatesEvolving treatment paradigmsAdjuvant therapyPatients with early stageRecent data updates hepatocellular carcinomaHcc treatmentsHepatocellular carcinoma treatmentsEarly stage hepatocellular carcinomaHcc risk factorsPatients with hccHcc prognosisHepatocellular carcinoma prognosisHepatocellular carcinoma diagnosisClinical work upMolecular testing hcc

Factoring Stage and Hepatic Function Into Treatment Decision-Making for HCC

The panel explains the Child-Pugh scoring system and how staging and liver function impact treatment decisions for patients with HCC.

Hepatocellular carcinomaRecent updatesEvolving treatment paradigmsHepatic function into treatment decision makingRecent data updates hepatocellular carcinomaHcc treatmentsHepatocellular carcinoma treatmentsEarly stage hepatocellular carcinomaHcc risk factorsPatients with hccHcc prognosisHepatocellular carcinoma prognosisHepatocellular carcinoma diagnosisClinical work upMolecular testing hccHcc diagnosis challenges

vimarsana © 2020. All Rights Reserved.